Trabanco Andrés Avelino, Alonso José Manuel, Andrés José Ignacio, Cid José Maria, Fernández Javier, Iturrino Laura, Megens Anton
Johnson & Johnson Pharmaceutical Research & Development, a Division of Janssen-Cilag SA, Toledo, Spain.
Chem Pharm Bull (Tokyo). 2004 Feb;52(2):262-5. doi: 10.1248/cpb.52.262.
New synthesis approaches that have led to a series of novel tetrahydrodibenzo[b,f]furo[2,3-d]oxepin derivatives are described. According to preliminary data these novel tetracycles can be useful intermediates for the preparation of potential new therapeutic agents.